COVID-19 Impact on Global Migraine Drugs, Market Insights and Forecast to 2026

COVID-19 Impact on Global Migraine Drugs, Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Migraine Drugs Product Introduction
1.2 Market Segments
1.3 Key Migraine Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Migraine Drugs Market Size Growth Rate by Type
1.4.2 Sumatriptan
1.4.3 Zolmitriptan
1.4.4 Rizatriptan
1.4.5 Others Drug
1.5 Market by Application
1.5.1 Global Migraine Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Household Use
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Migraine Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Migraine Drugs Industry
1.6.1.1 Migraine Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Migraine Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Migraine Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Migraine Drugs Market Size Estimates and Forecasts
2.1.1 Global Migraine Drugs Revenue 2015-2026
2.1.2 Global Migraine Drugs Sales 2015-2026
2.2 Migraine Drugs Market Size by Region: 2020 Versus 2026
2.2.1 Global Migraine Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Migraine Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Migraine Drugs Competitor Landscape by Players
3.1 Migraine Drugs Sales by Manufacturers
3.1.1 Migraine Drugs Sales by Manufacturers (2015-2020)
3.1.2 Migraine Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Migraine Drugs Revenue by Manufacturers
3.2.1 Migraine Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Migraine Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Migraine Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Migraine Drugs Revenue in 2019
3.2.5 Global Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Migraine Drugs Price by Manufacturers
3.4 Migraine Drugs Manufacturing Base Distribution, Product Types
3.4.1 Migraine Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Migraine Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Migraine Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Migraine Drugs Market Size by Type (2015-2020)
4.1.1 Global Migraine Drugs Sales by Type (2015-2020)
4.1.2 Global Migraine Drugs Revenue by Type (2015-2020)
4.1.3 Migraine Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Migraine Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Migraine Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Migraine Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Migraine Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Migraine Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Migraine Drugs Market Size by Application (2015-2020)
5.1.1 Global Migraine Drugs Sales by Application (2015-2020)
5.1.2 Global Migraine Drugs Revenue by Application (2015-2020)
5.1.3 Migraine Drugs Price by Application (2015-2020)
5.2 Migraine Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Migraine Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Migraine Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Migraine Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Migraine Drugs by Country
6.1.1 North America Migraine Drugs Sales by Country
6.1.2 North America Migraine Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Migraine Drugs Market Facts & Figures by Type
6.3 North America Migraine Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Migraine Drugs by Country
7.1.1 Europe Migraine Drugs Sales by Country
7.1.2 Europe Migraine Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Migraine Drugs Market Facts & Figures by Type
7.3 Europe Migraine Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Migraine Drugs by Region
8.1.1 Asia Pacific Migraine Drugs Sales by Region
8.1.2 Asia Pacific Migraine Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Migraine Drugs Market Facts & Figures by Type
8.3 Asia Pacific Migraine Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Migraine Drugs by Country
9.1.1 Latin America Migraine Drugs Sales by Country
9.1.2 Latin America Migraine Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Migraine Drugs Market Facts & Figures by Type
9.3 Central & South America Migraine Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Migraine Drugs by Country
10.1.1 Middle East and Africa Migraine Drugs Sales by Country
10.1.2 Middle East and Africa Migraine Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Migraine Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Migraine Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description, Business Overview and Total Revenue
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Migraine Drugs Products Offered
11.1.5 Allergan Recent Development
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description, Business Overview and Total Revenue
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Migraine Drugs Products Offered
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description, Business Overview and Total Revenue
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Migraine Drugs Products Offered
11.3.5 Pfizer Recent Development
11.4 Teva
11.4.1 Teva Corporation Information
11.4.2 Teva Description, Business Overview and Total Revenue
11.4.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Teva Migraine Drugs Products Offered
11.4.5 Teva Recent Development
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description, Business Overview and Total Revenue
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Migraine Drugs Products Offered
11.5.5 Pfizer Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson & Johnson Migraine Drugs Products Offered
11.6.5 Johnson & Johnson Recent Development
11.7 Endo International
11.7.1 Endo International Corporation Information
11.7.2 Endo International Description, Business Overview and Total Revenue
11.7.3 Endo International Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Endo International Migraine Drugs Products Offered
11.7.5 Endo International Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline Migraine Drugs Products Offered
11.8.5 GlaxoSmithKline Recent Development
11.9 Impax
11.9.1 Impax Corporation Information
11.9.2 Impax Description, Business Overview and Total Revenue
11.9.3 Impax Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Impax Migraine Drugs Products Offered
11.9.5 Impax Recent Development
11.10 Abbott
11.10.1 Abbott Corporation Information
11.10.2 Abbott Description, Business Overview and Total Revenue
11.10.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Abbott Migraine Drugs Products Offered
11.10.5 Abbott Recent Development
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description, Business Overview and Total Revenue
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Migraine Drugs Products Offered
11.1.5 Allergan Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Corporation Information
11.12.2 Eli Lilly Description, Business Overview and Total Revenue
11.12.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Eli Lilly Products Offered
11.12.5 Eli Lilly Recent Development
11.13 Ethypharm
11.13.1 Ethypharm Corporation Information
11.13.2 Ethypharm Description, Business Overview and Total Revenue
11.13.3 Ethypharm Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Ethypharm Products Offered
11.13.5 Ethypharm Recent Development
11.14 Kowa Pharmaceuticals America
11.14.1 Kowa Pharmaceuticals America Corporation Information
11.14.2 Kowa Pharmaceuticals America Description, Business Overview and Total Revenue
11.14.3 Kowa Pharmaceuticals America Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Kowa Pharmaceuticals America Products Offered
11.14.5 Kowa Pharmaceuticals America Recent Development
11.15 Winston Pharmaceuticals
11.15.1 Winston Pharmaceuticals Corporation Information
11.15.2 Winston Pharmaceuticals Description, Business Overview and Total Revenue
11.15.3 Winston Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Winston Pharmaceuticals Products Offered
11.15.5 Winston Pharmaceuticals Recent Development
11.16 AstraZeneca
11.16.1 AstraZeneca Corporation Information
11.16.2 AstraZeneca Description, Business Overview and Total Revenue
11.16.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.16.4 AstraZeneca Products Offered
11.16.5 AstraZeneca Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Migraine Drugs Market Estimates and Projections by Region
12.1.1 Global Migraine Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Migraine Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Migraine Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Migraine Drugs Sales Forecast (2021-2026)
12.2.2 North America: Migraine Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Migraine Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Migraine Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Migraine Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Migraine Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Migraine Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Migraine Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Migraine Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Migraine Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Migraine Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Migraine Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Migraine Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Migraine Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Migraine Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Migraine Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Migraine Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Migraine Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Migraine Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Migraine Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Migraine Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Migraine Drugs Market Segments
Table 2. Ranking of Global Top Migraine Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Migraine Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Sumatriptan
Table 5. Major Manufacturers of Zolmitriptan
Table 6. Major Manufacturers of Rizatriptan
Table 7. Major Manufacturers of Others Drug
Table 8. COVID-19 Impact Global Market: (Four Migraine Drugs Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Migraine Drugs Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Migraine Drugs Players to Combat Covid-19 Impact
Table 13. Global Migraine Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 14. Global Migraine Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 15. Global Migraine Drugs Sales by Regions 2015-2020 (K MT)
Table 16. Global Migraine Drugs Sales Market Share by Regions (2015-2020)
Table 17. Global Migraine Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Migraine Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 19. Global Migraine Drugs Sales Share by Manufacturers (2015-2020)
Table 20. Global Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Migraine Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Migraine Drugs as of 2019)
Table 22. Migraine Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Migraine Drugs Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Migraine Drugs Price (2015-2020) (USD/MT)
Table 25. Migraine Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Migraine Drugs Product Type
Table 27. Date of International Manufacturers Enter into Migraine Drugs Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Migraine Drugs Sales by Type (2015-2020) (K MT)
Table 30. Global Migraine Drugs Sales Share by Type (2015-2020)
Table 31. Global Migraine Drugs Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Migraine Drugs Revenue Share by Type (2015-2020)
Table 33. Migraine Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 34. Global Migraine Drugs Sales by Application (2015-2020) (K MT)
Table 35. Global Migraine Drugs Sales Share by Application (2015-2020)
Table 36. North America Migraine Drugs Sales by Country (2015-2020) (K MT)
Table 37. North America Migraine Drugs Sales Market Share by Country (2015-2020)
Table 38. North America Migraine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Migraine Drugs Revenue Market Share by Country (2015-2020)
Table 40. North America Migraine Drugs Sales by Type (2015-2020) (K MT)
Table 41. North America Migraine Drugs Sales Market Share by Type (2015-2020)
Table 42. North America Migraine Drugs Sales by Application (2015-2020) (K MT)
Table 43. North America Migraine Drugs Sales Market Share by Application (2015-2020)
Table 44. Europe Migraine Drugs Sales by Country (2015-2020) (K MT)
Table 45. Europe Migraine Drugs Sales Market Share by Country (2015-2020)
Table 46. Europe Migraine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Migraine Drugs Revenue Market Share by Country (2015-2020)
Table 48. Europe Migraine Drugs Sales by Type (2015-2020) (K MT)
Table 49. Europe Migraine Drugs Sales Market Share by Type (2015-2020)
Table 50. Europe Migraine Drugs Sales by Application (2015-2020) (K MT)
Table 51. Europe Migraine Drugs Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Migraine Drugs Sales by Region (2015-2020) (K MT)
Table 53. Asia Pacific Migraine Drugs Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Migraine Drugs Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Migraine Drugs Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Migraine Drugs Sales by Type (2015-2020) (K MT)
Table 57. Asia Pacific Migraine Drugs Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Migraine Drugs Sales by Application (2015-2020) (K MT)
Table 59. Asia Pacific Migraine Drugs Sales Market Share by Application (2015-2020)
Table 60. Latin America Migraine Drugs Sales by Country (2015-2020) (K MT)
Table 61. Latin America Migraine Drugs Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Migraine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Migraine Drugs Revenue Market Share by Country (2015-2020)
Table 64. Latin America Migraine Drugs Sales by Type (2015-2020) (K MT)
Table 65. Latin America Migraine Drugs Sales Market Share by Type (2015-2020)
Table 66. Latin America Migraine Drugs Sales by Application (2015-2020) (K MT)
Table 67. Latin America Migraine Drugs Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Migraine Drugs Sales by Country (2015-2020) (K MT)
Table 69. Middle East and Africa Migraine Drugs Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Migraine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Migraine Drugs Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Migraine Drugs Sales by Type (2015-2020) (K MT)
Table 73. Middle East and Africa Migraine Drugs Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Migraine Drugs Sales by Application (2015-2020) (K MT)
Table 75. Middle East and Africa Migraine Drugs Sales Market Share by Application (2015-2020)
Table 76. Allergan Corporation Information
Table 77. Allergan Description and Major Businesses
Table 78. Allergan Migraine Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Allergan Product
Table 80. Allergan Recent Development
Table 81. Merck Corporation Information
Table 82. Merck Description and Major Businesses
Table 83. Merck Migraine Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Merck Product
Table 85. Merck Recent Development
Table 86. Pfizer Corporation Information
Table 87. Pfizer Description and Major Businesses
Table 88. Pfizer Migraine Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Pfizer Product
Table 90. Pfizer Recent Development
Table 91. Teva Corporation Information
Table 92. Teva Description and Major Businesses
Table 93. Teva Migraine Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Teva Product
Table 95. Teva Recent Development
Table 96. Pfizer Corporation Information
Table 97. Pfizer Description and Major Businesses
Table 98. Pfizer Migraine Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Pfizer Product
Table 100. Pfizer Recent Development
Table 101. Johnson & Johnson Corporation Information
Table 102. Johnson & Johnson Description and Major Businesses
Table 103. Johnson & Johnson Migraine Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Johnson & Johnson Product
Table 105. Johnson & Johnson Recent Development
Table 106. Endo International Corporation Information
Table 107. Endo International Description and Major Businesses
Table 108. Endo International Migraine Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Endo International Product
Table 110. Endo International Recent Development
Table 111. GlaxoSmithKline Corporation Information
Table 112. GlaxoSmithKline Description and Major Businesses
Table 113. GlaxoSmithKline Migraine Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. GlaxoSmithKline Product
Table 115. GlaxoSmithKline Recent Development
Table 116. Impax Corporation Information
Table 117. Impax Description and Major Businesses
Table 118. Impax Migraine Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Impax Product
Table 120. Impax Recent Development
Table 121. Abbott Corporation Information
Table 122. Abbott Description and Major Businesses
Table 123. Abbott Migraine Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Abbott Product
Table 125. Abbott Recent Development
Table 126. Bayer Corporation Information
Table 127. Bayer Description and Major Businesses
Table 128. Bayer Migraine Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. Bayer Product
Table 130. Bayer Recent Development
Table 131. Eli Lilly Corporation Information
Table 132. Eli Lilly Description and Major Businesses
Table 133. Eli Lilly Migraine Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 134. Eli Lilly Product
Table 135. Eli Lilly Recent Development
Table 136. Ethypharm Corporation Information
Table 137. Ethypharm Description and Major Businesses
Table 138. Ethypharm Migraine Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 139. Ethypharm Product
Table 140. Ethypharm Recent Development
Table 141. Kowa Pharmaceuticals America Corporation Information
Table 142. Kowa Pharmaceuticals America Description and Major Businesses
Table 143. Kowa Pharmaceuticals America Migraine Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 144. Kowa Pharmaceuticals America Product
Table 145. Kowa Pharmaceuticals America Recent Development
Table 146. Winston Pharmaceuticals Corporation Information
Table 147. Winston Pharmaceuticals Description and Major Businesses
Table 148. Winston Pharmaceuticals Migraine Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 149. Winston Pharmaceuticals Product
Table 150. Winston Pharmaceuticals Recent Development
Table 151. AstraZeneca Corporation Information
Table 152. AstraZeneca Description and Major Businesses
Table 153. AstraZeneca Migraine Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 154. AstraZeneca Product
Table 155. AstraZeneca Recent Development
Table 156. Global Migraine Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 157. Global Migraine Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 158. Global Migraine Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 159. Global Migraine Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 160. North America: Migraine Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 161. North America: Migraine Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Europe: Migraine Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 163. Europe: Migraine Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Asia Pacific: Migraine Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 165. Asia Pacific: Migraine Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 166. Latin America: Migraine Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 167. Latin America: Migraine Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Middle East and Africa: Migraine Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 169. Middle East and Africa: Migraine Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 171. Key Challenges
Table 172. Market Risks
Table 173. Main Points Interviewed from Key Migraine Drugs Players
Table 174. Migraine Drugs Customers List
Table 175. Migraine Drugs Distributors List
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Migraine Drugs Product Picture
Figure 2. Global Migraine Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Sumatriptan Product Picture
Figure 4. Zolmitriptan Product Picture
Figure 5. Rizatriptan Product Picture
Figure 6. Others Drug Product Picture
Figure 7. Global Migraine Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Household Use
Figure 11. Others
Figure 12. Migraine Drugs Report Years Considered
Figure 13. Global Migraine Drugs Market Size 2015-2026 (US$ Million)
Figure 14. Global Migraine Drugs Sales 2015-2026 (K MT)
Figure 15. Global Migraine Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Migraine Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Migraine Drugs Sales Market Share by Region in 2019
Figure 18. Global Migraine Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Migraine Drugs Revenue Market Share by Region in 2019
Figure 20. Global Migraine Drugs Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Migraine Drugs Revenue in 2019
Figure 22. Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Migraine Drugs Sales Market Share by Type (2015-2020)
Figure 24. Global Migraine Drugs Sales Market Share by Type in 2019
Figure 25. Global Migraine Drugs Revenue Market Share by Type (2015-2020)
Figure 26. Global Migraine Drugs Revenue Market Share by Type in 2019
Figure 27. Global Migraine Drugs Market Share by Price Range (2015-2020)
Figure 28. Global Migraine Drugs Sales Market Share by Application (2015-2020)
Figure 29. Global Migraine Drugs Sales Market Share by Application in 2019
Figure 30. Global Migraine Drugs Revenue Market Share by Application (2015-2020)
Figure 31. Global Migraine Drugs Revenue Market Share by Application in 2019
Figure 32. North America Migraine Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Migraine Drugs Sales Market Share by Country in 2019
Figure 35. North America Migraine Drugs Revenue Market Share by Country in 2019
Figure 36. U.S. Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Migraine Drugs Market Share by Type in 2019
Figure 41. North America Migraine Drugs Market Share by Application in 2019
Figure 42. Europe Migraine Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 43. Europe Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Migraine Drugs Sales Market Share by Country in 2019
Figure 45. Europe Migraine Drugs Revenue Market Share by Country in 2019
Figure 46. Germany Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 47. Germany Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 49. France Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. U.K. Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. Italy Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 55. Russia Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Migraine Drugs Market Share by Type in 2019
Figure 57. Europe Migraine Drugs Market Share by Application in 2019
Figure 58. Asia Pacific Migraine Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Migraine Drugs Sales Market Share by Region in 2019
Figure 61. Asia Pacific Migraine Drugs Revenue Market Share by Region in 2019
Figure 62. China Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. India Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. Australia Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. Taiwan Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Indonesia Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Thailand Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Malaysia Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Philippines Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 83. Vietnam Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Migraine Drugs Market Share by Type in 2019
Figure 85. Asia Pacific Migraine Drugs Market Share by Application in 2019
Figure 86. Latin America Migraine Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Migraine Drugs Sales Market Share by Country in 2019
Figure 89. Latin America Migraine Drugs Revenue Market Share by Country in 2019
Figure 90. Mexico Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Migraine Drugs Market Share by Type in 2019
Figure 97. Latin America Migraine Drugs Market Share by Application in 2019
Figure 98. Middle East and Africa Migraine Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Migraine Drugs Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Migraine Drugs Revenue Market Share by Country in 2019
Figure 102. Turkey Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Migraine Drugs M

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Narcolepsy Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 80

According to our LPI (LP Information) latest study, the global Narcolepsy Drug market size was valued at US$ 2715.1 million in 2023. With growing demand in downstream market, the Narcolepsy Drug is forecast to a readjusted size of US$ 5598.9 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Narcolepsy Drug market. Narcolepsy Drug are expected to show stable growth in the future market. However, product differentia......

Global Epilepsy Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 121

Market Overview of Global Epilepsy Drugs market: According to our latest research, the global Epilepsy Drugs market looks promising in the next 5 years. As of 2022, the global Epilepsy Drugs market was estimated at USD 4815.92 million, and it's anticipated to reach USD 6053.85 million in 2028, with a CAGR of 3.89% during the forecast years. Anti-epileptic drugs can eliminate or reduce seizures in two ways. One is to affect central neurons to prevent or reduce their pathologic......

Global Neuromyelitis Optica Drug Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107

According to our LPI (LP Information) latest study, the global Neuromyelitis Optica Drug market size was valued at US$ 46 million in 2023. With growing demand in downstream market, the Neuromyelitis Optica Drug is forecast to a readjusted size of US$ 57 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Neuromyelitis Optica Drug market. Neuromyelitis Optica Drug are expected to show stable growth in the future marke......

Migraine Drugs - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118

The global Migraine Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Migraine Drugs in various end use industries. The expanding demands from the Hospitals, Clinics, Household Use and Others, are propelling Migraine Drugs market. Sumatriptan, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......

Global Neuromyelitis Optica Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 121

Market Overview of Global Neuromyelitis Optica Drug market: According to our latest research, the global Neuromyelitis Optica Drug market looks promising in the next 5 years. As of 2022, the global Neuromyelitis Optica Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......

Global Narcolepsy Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Narcolepsy Drug market: According to our latest research, the global Narcolepsy Drug market looks promising in the next 5 years. As of 2022, the global Narcolepsy Drug market was estimated at USD 2915.59 million, and it's anticipated to reach USD 5983.81 million in 2028, with a CAGR of 12.73% during the forecast years. Narcolepsy is a neurological disorder characterized by the brain's inability to control sleep/wakefulness cycles. This......

Global Edaravone Market Research Report 2023

Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 88

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Edaravone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Mitsubishi Tanabe Pharma - Simcere - Taj Pharmaceuticals Ltd. - Sun Pharmaceutical Industries Ltd. - Unichem Laboratories Ltd - UCB India Ltd - Piram......

Global Ethoxyquin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Ethoxyquin market: According to our latest research, the global Ethoxyquin market looks promising in the next 5 years. As of 2022, the global Ethoxyquin market was estimated at USD 216.07 million, and it's anticipated to reach USD 303.42 million in 2028, with a CAGR of 5.82% during the forecast years. Ethoxyquin (EQ) is a clear, viscous, light yellow to dark brown liquid, with an unpleasant, mercaptan-like smell, that causes irritation of the skin an......

Global Antipsychotic Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Antipsychotic Drugs market: According to our latest research, the global Antipsychotic Drugs market looks promising in the next 5 years. As of 2022, the global Antipsychotic Drugs market was estimated at USD 15363.6 million, and it's anticipated to reach USD 23658.8 million in 2028, with a CAGR of 7.46% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global An......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs